Title for MeetingAbstracts
Alphabetical listing of titles
Volunteers, an illusion in poor communities.
von Willebrand factor limits the elevation of bleeding time in thrombopenic HIV-infected patients.
Voriconazole (V) Use in Liver Transplant (LT) Recipients with Invasive Fungal Infection.
Voriconazole (VCZ) for Bone Aspergillosis (BA): a Worldwide Experience of 19 Cases.
Voriconazole (VRC) Therapy (Rx) in 86 Patients (pts) with CNS Aspergillosis (CNSA): a Retrospective Analysis.
Voriconazole as Secondary Prophylaxis for Leukemic Patients with Previous Invasive Fungal Diseases and Going to a New At-Risk Phase.
Voriconazole as Therapy for Systemic Infections Caused by Penicillium marneffei in Patients with HIV Infection.
Voriconazole Does Not Affect the Pharmacokinetics of Digoxin.
Voriconazole Does Not Affect the Pharmacokinetics of Mycophenolic Acid.
Voriconazole in the successful treatment of vertebral osteomyelitis caused by Aspergillus fumigatus.
Voriconazole Inhibition of Tacrolimus Metabolism after Liver Transplantation and in Human Liver Microsomes.
Voriconazole Is Highly Active against the 14alpha-Demethylase of Candida krusei.
Voriconazole Potentiates Warfarin-Induced Prolongation of Prothrombin Time.
Voriconazole Treatment for Pulmonary Cryptococcosis.
Voriconazole Versus Liposomal Amphotericin B for Empirical Antifungal Therapy of Persistently Febrile Neutropenic Patients: a Randomized, International, Multicenter Trial.
Voting patterns in rural state verify accuracy of perceptions of persons living with HIV.
Voting with Their Feet: Consumers' Decision to Disenroll from Healthplans.
Voting with Their Feet: Exit, Racial Differences, and Some Cautionary Notes.
Vouchers as an alternative for premium regulation on a competitive individual health insurance market.
Vouchers attract high-risk patients to drug treatment.
VP-14637 and R-170591 Share the Same Mechanism of Activity against Respiratory Syncytial Virus (RSV).
VP1 Sequencing of All Human Rhinovirus Serotypes: Insights into Genus Phylogeny and Susceptibility to Pleconaril.
Vpr is the key regulator of HIV-1 nuclear import.
Vpr Mutation R77Q Is Associated with Long-Term Non-Progressive HIV-Infection and an Impaired Ability to Induce T-Cell Depletion in Vivo.
Vpu - a protein unique for HIV-1 is required for efficient virion maturation and release.
vpu affects the ability of HIV-1 to replicate and form syncytia in cells expressing high levels of CD4.
Vpu channel blockers inhibit in vitro HIV-1 replication.
Vpu-dependent virus release is cell type specific and may involve an interaction with a cellular protein.
Vpu-induced CD4 degradation requires the function of proteasomes and the ubiquitin conjugating pathway.
VRC4219, a Novel Bactericidal Antibiotic with In Vivo Efficacy.